These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12759581

  • 1. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM, Klotz CH, Czock D, Karges W, Muche R, Jehle PM, Mertz A, Keller F.
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [Abstract] [Full Text] [Related]

  • 2. Sequential immunosuppressive therapy in progressive IgA nephropathy.
    Rasche FM, Keller F, von Müller L, Czock D, Lepper PM.
    Contrib Nephrol; 2007; 157():109-13. PubMed ID: 17495446
    [Abstract] [Full Text] [Related]

  • 3. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA, Lohavichan V, Hennigar R.
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [Abstract] [Full Text] [Related]

  • 4. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 Jul; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 5. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Jul; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 6. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
    Mitsuiki K, Harada A, Okura T, Higaki J.
    Clin Exp Nephrol; 2007 Dec; 11(4):297-303. PubMed ID: 18085391
    [Abstract] [Full Text] [Related]

  • 7. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 8. Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.
    Rasche FM, Keller F, Rasche WG, Schiekofer S, Kahn T, Fahnert J.
    Clin Exp Immunol; 2016 Feb; 183(2):307-16. PubMed ID: 26439797
    [Abstract] [Full Text] [Related]

  • 9. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
    Tumlin JA, Hennigar RA.
    Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
    Rasche FM, Keller F, von Müller L, Sailer LK, Karges W, Czock D.
    J Nephrol; 2006 May; 19(4):465-72. PubMed ID: 17048204
    [Abstract] [Full Text] [Related]

  • 11. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
    Ishii T, Kawamura T, Tsuboi N, Ogura M, Utsunomiya Y, Hosoya T.
    Contrib Nephrol; 2007 May; 157():114-9. PubMed ID: 17495447
    [Abstract] [Full Text] [Related]

  • 12. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
    Ballardie FW, Roberts ISD.
    J Am Soc Nephrol; 2002 Jan; 13(1):142-148. PubMed ID: 11752031
    [Abstract] [Full Text] [Related]

  • 13. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Jan; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 14. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 15. Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
    Hwang YC, Lee TW, Kim MJ, Yang MH, Ihm CG.
    Korean J Intern Med; 2001 Jun 06; 16(2):105-9. PubMed ID: 11590896
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.
    Tamura S, Ueki K, Ideura H, Tsukada Y, Maezawa A, Kawai H, Wakamatsu R, Yano S, Nojima Y, Naruse T.
    Clin Nephrol; 2001 Mar 06; 55(3):192-5. PubMed ID: 11316238
    [Abstract] [Full Text] [Related]

  • 17. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan 06; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 18. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
    Ramachandran R, Doddi P, Nandakrishna B, Nada R, Kumar V, Rathi M, Kohli HS, Jha V, Sakhuja V, Gupta KL.
    Int Urol Nephrol; 2015 Nov 06; 47(11):1917-8. PubMed ID: 26411427
    [No Abstract] [Full Text] [Related]

  • 19. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 06; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 20. Advanced IgA nephropathy: to treat or not to treat?
    Locatelli F, Pozzi M, Del Vecchio L, Pozzi C.
    Nephron Clin Pract; 2003 Sep 06; 93(4):c119-21. PubMed ID: 12759578
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.